Congenital Corneal Opacities: A Review with a Focus on Genetics

REFERENCES

• Bermejo E, Martinez-Frias M L. Congenital eye malformations: clinical epidemiological analysis of 1,124,654 consecutive births in Spain. Am J Med Genet. 1998; 75: 497–504
   PubMed Web of Science ®Google Scholar
• Rezende R A, Uchoa U B, Uchoa R, Rapuano C J, Laibson P R, Cohen E J. Congenital corneal opacities in a cornea referral practice. Cornea Aug, 2004; 23(6)565–70
   PubMed Web of Science ®Google Scholar
• Dana M R, Schaumberg D A, et al. Corneal transplantation in children with Peters Anomaly and Mesenchymal Dysgeneses. Multicenter Pediatric Keratoplasty Study. Ophthalmology Oct, 1997; 104(10)1580–6
   PubMed Web of Science ®Google Scholar
• Frueh B E, Brown S I. Transplantation of congenitally opaque corneas. Br J Ophthalmol. Dec, 1997; 81(12)1064–9
   PubMed Web of Science ®Google Scholar
• Comer R M, Daya S M, O'Keefe M. Penetrating keratoplasty in infants. J AAPOS Oct, 2001; 5(5)285–90
   PubMed Web of Science ®Google Scholar
• Peters A. Ueber angeborene Defektbildung der Descemetschen Membran. Klin Monatsbl Augenheilkd 1906; 44: 27–40
   Google Scholar
• Stone D L, Kenyon K R, Green W R, Ryan S J. Congenital central corneal leukoma (Peters' anomaly). Am J Ophthalmol 1976; 81(2)173–93
   Google Scholar
• Albert D, Jakobiec F, et al. Principles and Practice of Ophthalmology. 2nd edition. WB Saunders Publishers, Philadelphia 1999; 701
   Google Scholar
• Reese A B, Ellsworth R M. The anterior chamber cleavage syndrome. Ophthalmology Mar, 1966; 75(3)307–18
   Google Scholar
• Traboulsi E J, Maumenee I H. Peters' anomaly and associated congenital malformations. Arch Ophthalmol. Dec, 1992; 110(12)1739–42
   Google Scholar
• Ozeki H, Shirai S, Nozaki M, et al. Ocular and systemic features of Peters' anomaly. Graefes Arch Clin Exp Ophthalmol Oct, 2000; 238(10)833–9
   Web of Science ®Google Scholar
• Van Schooneveld M J, Delleman J W, Beemer F A, Bleeker-Wagemakers E M. Peters'-plus: a new syndrome. Ophthalmic Paediatr Genet Dec, 1984; 4(3)141–5
   Web of Science ®Google Scholar
• Holmstrom G E, Reardon W P, et al. Heterogeneity in dominant anterior segment malformations. Br J Ophthalmol Oct, 1991; 75(10)591–7
   Google Scholar
• Kivlin J D, Fineman R M, Crandall A S, et al. Peters' anomaly as a consequence of genetic and nongenetic syndromes. Arch Ophthalmol. 1986; 104: 61–64
   Google Scholar
• David D, Cardosa J, et al. Molecular characterization of a familial translocation implicates disruption of a HDAC9 and possible position effect on TGFbeta2 in the pathogenesis of Peters' anomaly. Genomics May, 2003; 81(5)489–503
   Google Scholar
• Bahn C F, Falls H F, et al. Classification of corneal endothelial disorders based on neural crest origin. Ophthalmology Jun, 1984; 91(6)558–63
   Google Scholar
• Vincent A, Billingsley G, et al. Further support of the role of CYP1B1 in patients with Peters anomaly. Mol Vis. Jan, 1986; 104(1)61–64
   Google Scholar
• Hanson I M, Fletcher J M, et al. Mutations at the PAX6 locus are found in heterogeneous anterior segment malformations including Peters' anomaly. Nat Genet Feb, 1994; 6(2)168–73
   PubMed Web of Science ®Google Scholar
• Churchill A J, Booth A P, et al. PAX6 is normal in most cases of Peters' anomaly. Eye 1998; 12: 299–303, (Pt 2)
   Google Scholar
• Doward W, Perveen R, et al. A mutation in the RIEG1 gene associated with Peters' anomaly. J Med Genet Feb, 1999; 36(2)152–5
   PubMed Web of Science ®Google Scholar
• Churchill A J, Yeung A. A compound heterozygous change found in Peters' anomaly. Mol Vis. Jan 21, 2005; 11: 66–70
   PubMed Web of Science ®Google Scholar
• Vincent A, Billingsley G, et al. Phenotypic heterogeneity of CYP1B1: mutations in a patient with Peters' anomaly. J Med Genet May, 2001; 38(5)324–6
   Google Scholar
• Stoilov I, Akarsu A N, et al. Sequence analysis and homology modeling suggest that primary congenital glaucoma on 2p21 results from mutations disrupting either the hinge region or the conserved core structures of cytochrome P4501B1. Am J Hum Genet Mar, 1998; 62(3)573–84
   PubMed Web of Science ®Google Scholar
• Edward D, Al Rajhi A, et al. Molecular basis of Peters anomaly in Saudi Arabia. Ophthalmic Genet. Dec, 2004; 25(4)257–70
   PubMedGoogle Scholar
• Honkanen R A, Nishimura D Y, et al. A family with Axenfeld-Rieger syndrome and Peters Anomaly caused by a point mutation (Phe112Ser) in the FOXC1 gene. Am J Ophthalmol Mar, 2003; 135(3)368–75
   PubMed Web of Science ®Google Scholar
• Yang L L, Lambert S R, et al. Surgical management of glaucoma in infants and children with Peters' anomaly: long-term structural and functional outcome. Ophthalmology Jan, 2004; 111(1)112–7
   PubMed Web of Science ®Google Scholar
• Yang L L, Lambert S R, et al. Long-term results of corneal graft survival in infants and children with Peters' anomaly. Ophthalmology Apr, 1999; 106(4)833–48
   PubMed Web of Science ®Google Scholar
• Yang L L, Lambert S R. Peters' anomaly. A synopsis of surgical management and visual outcome. Ophthalmol Clin North Am. Sep, 2001; 14(3)467–77
   Google Scholar
• Maumenee A E. Congenital hereditary corneal dystrophy. Am J Ophthalmol Dec, 1960; 50: 1114–24
   PubMedGoogle Scholar
• Judisch G F, Maumenee I H. Clinical differentiation of recessive congenital hereditary endothelial dystrophy and dominant hereditary endothelial dystrophy. Am J Ophthalmol May, 1978; 85: 606–12
   PubMed Web of Science ®Google Scholar
• Kirkness C M, McCartney A, et al. Congenital hereditary corneal oedema of Maumenee: its clinical features, management, and pathology. Br J Ophthalmol Feb, 1987; 71(2)130–44
   Google Scholar
• Ehlers N, Modis L, Moller-Pedersen T. A morphological and functional study of Congenital Hereditary Endothelial Dystrophy. Acta Ophthalmol Scand. Jun, 1998; 76(3)314–8
   Google Scholar
• Toma N M, Ebenezer N D, Inglehearn C F, et al. Linkage of congenital hereditary endothelial dystrophy to chromosome 20. Hum Mol Genet. Dec, 1995; 4(12)2395–8
   Google Scholar
• Heon E, Mathers W D, et al. Linkage of posterior polymorphous dystrophy to 20q11. Hum. Mol. Genet. March, 1995; 4(3)485–8
   Google Scholar
• Callaghan M, Hand C K, et al. Homozygosity mapping and linkage analysis demonstrate that autosomal recessive congenital hereditary endothelial dystrophy (CHED) and autosomal dominant CHED are genetically distinct. Br J Ophthalmol. Jan, 1999; 83(1)115–9
   PubMed Web of Science ®Google Scholar
• Hand C K, Harmon D L, et al. Localization of the gene for autosomal recessive congenital hereditary endothelial dystrophy (CHED2) to chromosome 20 by homozygosity mapping. Genomics Oct 1, 1999; 61(1)1–4
   PubMed Web of Science ®Google Scholar
• Vithana E N, Morgan P, et al. Mutations in sodium-borate cotransporter SLC4A11 cause recessive congenital hereditary endothelial dystrophy (CHED2). Nat Genet. Jul, 2006; 38(7)755–7
   PubMed Web of Science ®Google Scholar
• Jiao X, Sultana A. Autosomal recessive corneal endothelial dystrophy (CHED2) is associated with mutations in SLC4A11. J Med Genet. Jan, 2007; 44(1)64–68
   PubMedGoogle Scholar
• Javadi M A, Baradaran-Rafii A R, et al. Penetrating keratoplasty in young children with congenital hereditary endothelial dystrophy. Cornea Jul, 2003; 22(5)420–3
   PubMed Web of Science ®Google Scholar
• Al-Rajhi A A, Wagoner M D. Penetrating keratoplasty in congenital hereditary endothelial dystrophy. Ophthalmology Jun, 1997; 104(6)956–61
   Google Scholar
• Sajjadi H, Javadi M A, et al. Results of penetrating keratoplasty in CHED. Congenital hereditary endothelial dystrophy. Cornea Jan, 1995; 14(1)18–25
   Web of Science ®Google Scholar
• Bredrup C, Knappskog P M, et al. Congenital stromal dystrophy of the cornea caused by a mutation in the decorin gene. Invest Ophthalmol Vis Sci. Feb, 2005; 46(2)420–6
   Google Scholar
• Albert D, Jakobiec F, et al. Principles and Practice of Ophthalmology. 2nd edition. WB Saunders Publishers, Philadelphia 1999; 724
   Google Scholar
• Van Ginderdeuren R, De Vos R, et al. Report of a new family with dominant congenital hereditary stromal dystrophy of the cornea. Cornea Jan, 2002; 21(1)118–120
   Google Scholar
• Rodahl E, van Ginderdeuren R, et al. A second decorin frame shift mutation in a family with congenital stromal corneal dystrophy. Am J Ophthalmol Sep, 2006; 142(3)520–1
   Google Scholar
• Koeppe L. Klinische Beobachtungen mit der Nernstspaltlampe und dem Hornhautmikroskop. Albrecht Von Graefes Arch Klin Exp Ophthalmol. 1916; 91: 363–79
   Google Scholar
• Cibis G W, Krachmer J A, et al. The clinical spectrum of posterior polymorphous dystrophy. Arch Ophthalmol 1977; 95(9)1529–37
   Google Scholar
• Moroi S E, Gokhale P A, et al. Clinicopathologic Correlation and Genetic Analysis in a Case of Posterior Polymorphous Corneal Dystrophy. Am J Ophthalmol Apr, 2003; 135(4)461–70
   PubMed Web of Science ®Google Scholar
• Krachmer J H. Posterior polymorphous corneal dystrophy: a disease characterized by epithelial-like endothelial cells which influence management and prognosis. Trans Am Ophthalmol Soc 1985; 83: 413–75
   PubMedGoogle Scholar
• Heon E, Mathers W D, et al. Linkage of posterior polymorphous corneal dystrophy to 20q11. Hum. Mol. Genet. Mar, 1995; 4(3)485–88
   Google Scholar
• Heon E, Greenberg A, et al. VSX1: a gene for posterior polymorphous dystrophy and keratoconus. Hum Mol Genet. May 1, 2002; 11(9)1029–36
   PubMed Web of Science ®Google Scholar
• Gwilliam R, Liskova P, et al. Posterior polymorphous corneal dystrophy in Czech families maps to chromosome 20 and excludes the VSX1 gene. Invest Ophthalmol Vis Sci Dec, 2005; 46(12)4480–4
   Google Scholar
• Biswas S, Munier F L, et al. Missense mutations in COL8A2, the gene encoding the alpha2 chain of type VIII collagen, cause two forms of corneal endothelial dystrophy. Hum Mol Genet Oct 1, 2001; 10(21)2415–23
   PubMed Web of Science ®Google Scholar
• Shimizu S, Krafchak C, et al. A locus for posterior polymorphous corneal dystrophy (PPCD3) maps to chromosome 10. Am J Med Genet A Nov 1, 2004; 130(4)372–7
   Google Scholar